Cytosorbents Crp (CTSO) — Cash Flow-to-Debt Ratio
Cytosorbents Crp (CTSO) has a Cash Flow-to-Debt Ratio of -0.05x as of June 2026, meaning its operating cash flow of $-1.75 Million could theoretically repay 0% of its total liabilities ($38.71 Million) in one year. See financial agility of Cytosorbents Crp to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cytosorbents Crp Cash Flow-to-Debt Ratio (2004–2025)
Historical debt coverage capacity for Cytosorbents Crp across 22 annual periods. For the full cash flow conversion analysis, see Cytosorbents Crp cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Cytosorbents Crp (2004–2025)
Year-by-year debt coverage analysis for Cytosorbents Crp. Check Cytosorbents Crp (CTSO) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.32x | $-12.38 Million | $38.28 Million | ▲ +18.7% |
| 2024 | -0.40x | $-14.43 Million | $36.26 Million | ▲ +44.9% |
| 2023 | -0.72x | $-21.66 Million | $29.99 Million | ▲ +28.7% |
| 2022 | -1.01x | $-28.23 Million | $27.86 Million | ▼ -95.0% |
| 2021 | -0.52x | $-14.01 Million | $26.94 Million | ▲ +0.6% |
| 2020 | -0.52x | $-5.61 Million | $10.73 Million | ▲ +25.2% |
| 2019 | -0.70x | $-16.76 Million | $23.96 Million | ▼ -2.0% |
| 2018 | -0.69x | $-10.84 Million | $15.81 Million | ▼ -46.9% |
| 2017 | -0.47x | $-6.46 Million | $13.84 Million | ▲ +29.5% |
| 2016 | -0.66x | $-6.73 Million | $10.17 Million | ▲ +77.6% |
| 2015 | -2.96x | $-9.01 Million | $3.04 Million | ▼ -100.2% |
| 2014 | -1.48x | $-6.66 Million | $4.51 Million | ▼ -675.8% |
| 2013 | -0.19x | $-3.49 Million | $18.31 Million | ▲ +21.1% |
| 2012 | -0.24x | $-3.62 Million | $14.96 Million | ▲ +88.6% |
| 2011 | -2.12x | $-3.83 Million | $1.80 Million | ▼ -96.7% |
| 2010 | -1.08x | $-2.48 Million | $2.30 Million | ▲ +60.8% |
| 2009 | -2.76x | $-2.67 Million | $970.76K | ▼ -19.7% |
| 2008 | -2.30x | $-2.37 Million | $1.03 Million | ▲ +20.6% |
| 2007 | -2.90x | $-2.63 Million | $906.87K | ▼ -10.0% |
| 2006 | -2.63x | $-2.85 Million | $1.08 Million | ▼ -437.0% |
| 2005 | -0.49x | $-50.00K | $101.97K | ▲ +11.7% |
| 2004 | -0.56x | $-50.00K | $90.00K | — |